First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
More stories
Genex
News Release
Genex Services Becomes Ticket to Work Provider
Social Security Initiative supports and protects people with disabilities who want to reenter workforce
Workers' Comp
White Paper
Proven track records create a winning formula for injured workers’ recoveries
The coronavirus pandemic has taught us much about disparities in health care.
Mitchell
News Release
New York State Workers' Compensation Board Announces Implementation Delay
The New York State Workers' Compensation Board announced on Monday, May 24, 2021, a delay in the implementation of the drug formulary for refills a
Genex
Blog
Transportation and translation: an unlikely but powerful duo
Recently, the Sounding Board sat down with Jim Begg, Vice President of National Accounts for Apricus, to talk about transportation and translation
Genex
CE Webinar
Knee Injuries: Trends and Advances [Recording]
On-Demand
Knee injuries make up a large percentage of medical insurance and health care claims in the orthopedic field.
Mitchell
News Release
FDA Approves Higher Dose Naloxone, Kloxxado
Naloxone has been known by different brand names over the years as the primary treatment of opioid overdose.